Krsnaa Diagnostics Ltd
NSE:KRSNAA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
538.35
972.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Krsnaa Diagnostics Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | IN |
Market Cap | 31.4B INR |
Net Margin |
10%
|
Country | US |
Market Cap | 91.8B USD |
Net Margin |
1%
|
Country | US |
Market Cap | 87.7B EUR |
Net Margin |
1%
|
Country | US |
Market Cap | 73B USD |
Net Margin |
1%
|
Country | DE |
Market Cap | 24.9B EUR |
Net Margin |
3%
|
Country | US |
Market Cap | 20.1B USD |
Net Margin |
3%
|
Country | DE |
Market Cap | 18.8B EUR |
Net Margin |
-2%
|
Country | US |
Market Cap | 18.3B USD |
Net Margin |
9%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
7%
|
Country | DE |
Market Cap | 12.4B EUR |
Net Margin |
3%
|
Country | AU |
Market Cap | 13.4B AUD |
Net Margin |
6%
|
Krsnaa Diagnostics Ltd
Glance View
Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The company is headquartered in Pune, Maharashtra. The company went IPO on 2021-08-16. The firm is focused on providing radiology and pathology services for -radiation (X-rays), computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. The firm operates within India and has diagnostic centers all over India. The Company' studies in CT Scan include Peripheral Angio, Urography, Coronary Angio, Cisternography, CT Brain, CT Abdomen Triple Phase, CT HRCT Temporal Bone, CT Dentascan, CT Brain Angio, CT Perfusion, CT Renal Angio, CT Aortography and CT Pulmonary Angio. The Company’s services in color doppler include upper limb arterial doppler, upper limb venous doppler, lower limb arterial doppler, lower limb venous doppler, carotid doppler, hepatosplenic doppler, obstetric doppler and scrotal doppler.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Krsnaa Diagnostics Ltd's most recent financial statements, the company has Net Margin of 10.2%.